China represents a unique and compelling market for cord blood and tissue banking. First, the Chinese government only supports one cord blood bank within each of the provinces. Specifically, the Chinese government issues one cord blood banking license per province, and the licensed company must function as hybrid “public and private” bank.
The private, for-profit division of the company is expected to fund the company’s public, donation-based division, because no government support is given to support its processing and storage of donated units.
In this article:
- China Cord Blood Corp
- Sanpower Group and Nanjing Cenbest
- Increase in Cord Blood Stock and Market
- Market Penetration Rates in China
- Clinical Trial Activity in China